Literature DB >> 16570300

Diffusion-weighted imaging in Huntington's disease.

Klaus Seppi1, Michael F H Schocke, Katherina J Mair, Regina Esterhammer, Helga Weirich-Schwaiger, Barbara Utermann, Karl Egger, Christian Brenneis, Roberta Granata, Sylvia Boesch, Werner Poewe, Gregor K Wenning.   

Abstract

Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder that results from an expanded trinucleotide (CAG) repeat on the huntingtin gene. Neurodegeneration in HD affects most prominently the basal ganglia. Therefore, diffusivity was obtained in the basal ganglia and thalamus of 29 patients with early HD and 27 healthy volunteers by means of the trace of the diffusion tensor (Trace(D)). Putaminal, caudate, pallidal, and thalamic Trace(D) values were increased in patients with HD compared with controls. Increased diffusivity in the putamen and caudate nucleus correlated with global functional impairment, CAG repeat length, as well as bicaudate ratio. Diffusion-weighted imaging appears to be a promising surrogate marker for disease severity in HD. Sensitivity to change remains to be established longitudinally. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Year:  2006        PMID: 16570300     DOI: 10.1002/mds.20868

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Joint reconstruction of white-matter pathways from longitudinal diffusion MRI data with anatomical priors.

Authors:  Anastasia Yendiki; Martin Reuter; Paul Wilkens; H Diana Rosas; Bruce Fischl
Journal:  Neuroimage       Date:  2015-12-21       Impact factor: 6.556

2.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

3.  Diffusion Tensor Imaging in Preclinical Huntington's Disease.

Authors:  Vincent A Magnotta; Jinsuh Kim; Tim Koscik; Leigh J Beglinger; Daisy Espinso; Doug Langbehn; Peg Nopoulos; Jane S Paulsen
Journal:  Brain Imaging Behav       Date:  2009-03-01       Impact factor: 3.978

Review 4.  The evolving role of diffusion magnetic resonance imaging in movement disorders.

Authors:  Christopher W Hess; Edward Ofori; Umer Akbar; Michael S Okun; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

5.  Monitoring Huntington's disease progression through preclinical and early stages.

Authors:  Chris Tang; Andrew Feigin
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

6.  Decreased diffusivity in the caudate nucleus of presymptomatic huntington disease gene carriers: which explanation?

Authors:  M L Mandelli; M Savoiardo; L Minati; C Mariotti; D Aquino; A Erbetta; S Genitrini; S Di Donato; M G Bruzzone; M Grisoli
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-26       Impact factor: 3.825

7.  Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease.

Authors:  Wim Vandenberghe; Philippe Demaerel; René Dom; Frederik Maes
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

8.  Altered diffusion tensor imaging measurements in aged transgenic Huntington disease rats.

Authors:  Bjørnar T Antonsen; Yi Jiang; Jelle Veraart; Hong Qu; Huu Phuc Nguyen; Jan Sijbers; Stephan von Hörsten; G Allan Johnson; Trygve B Leergaard
Journal:  Brain Struct Funct       Date:  2012-05-23       Impact factor: 3.270

Review 9.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

10.  Basal ganglia-cortical structural connectivity in Huntington's disease.

Authors:  Marianne J U Novak; Kiran K Seunarine; Clare R Gibbard; Peter McColgan; Bogdan Draganski; Karl Friston; Chris A Clark; Sarah J Tabrizi
Journal:  Hum Brain Mapp       Date:  2015-01-30       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.